Samsara BioCapital as of Dec. 31, 2023
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 41 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Scholar Rock Hldg Corp (SRRK) | 19.9 | $128M | 6.8M | 18.80 | |
Rayzebio | 17.9 | $115M | 1.8M | 62.17 | |
Cargo Therapeutics (CRGX) | 14.8 | $95M | 4.1M | 23.15 | |
Mineralys Therapeutics (MLYS) | 6.0 | $39M | 4.5M | 8.60 | |
Arcellx Common Stock (ACLX) | 4.0 | $26M | 460k | 55.50 | |
Neurogene (NGNE) | 3.8 | $25M | 1.3M | 19.38 | |
Graphite Bio | 3.4 | $22M | 8.5M | 2.62 | |
Nkarta (NKTX) | 2.9 | $19M | 2.9M | 6.60 | |
Acelyrin (SLRN) | 2.9 | $19M | 2.5M | 7.46 | |
Zymeworks Del (ZYME) | 2.4 | $15M | 1.5M | 10.39 | |
Lyra Therapeutics (LYRA) | 2.3 | $15M | 2.8M | 5.24 | |
Syros Pharmaceuticals Com New (SYRS) | 2.2 | $14M | 1.8M | 7.79 | |
Avadel Pharmaceuticals Sponsored Adr | 2.1 | $14M | 968k | 14.12 | |
Hillevax (HLVX) | 2.0 | $13M | 799k | 16.05 | |
Abivax Sa Sponsored Ads (ABVX) | 1.4 | $9.1M | 850k | 10.70 | |
Rhythm Pharmaceuticals (RYTM) | 1.2 | $7.9M | 173k | 45.97 | |
Sutro Biopharma (STRO) | 1.1 | $7.2M | 1.7M | 4.29 | |
Verona Pharma Sponsored Ads (VRNA) | 1.1 | $6.9M | 348k | 19.88 | |
Io Biotech (IOBT) | 1.1 | $6.8M | 3.6M | 1.88 | |
Inozyme Pharma (INZY) | 1.0 | $6.7M | 1.6M | 4.26 | |
Tango Therapeutics (TNGX) | 1.0 | $6.2M | 630k | 9.90 | |
Gossamer Bio (GOSS) | 0.9 | $5.6M | 6.1M | 0.91 | |
Immatics SHS (IMTX) | 0.6 | $4.2M | 396k | 10.53 | |
Prime Medicine (PRME) | 0.6 | $4.2M | 470k | 8.86 | |
Janux Therapeutics (JANX) | 0.6 | $3.9M | 360k | 10.73 | |
Pepgen (PEPG) | 0.5 | $3.0M | 437k | 6.80 | |
Day One Biopharmaceuticals I (DAWN) | 0.4 | $2.9M | 196k | 14.60 | |
Leap Therapeutics Com New (LPTX) | 0.4 | $2.8M | 669k | 4.14 | |
Rain Therapeutics | 0.4 | $2.4M | 2.0M | 1.20 | |
Terns Pharmaceuticals (TERN) | 0.2 | $1.3M | 202k | 6.49 | |
Igm Biosciences (IGMS) | 0.2 | $1.3M | 155k | 8.31 | |
Bolt Biotherapeutics (BOLT) | 0.2 | $1.2M | 1.0M | 1.12 | |
Aclaris Therapeutics (ACRS) | 0.1 | $731k | 696k | 1.05 | |
Vtv Therapeutics Cl A New (VTVT) | 0.1 | $470k | 41k | 11.50 | |
Allakos (ALLK) | 0.1 | $470k | 172k | 2.73 | |
Viracta Therapeutics (VIRX) | 0.1 | $393k | 690k | 0.57 | |
Science 37 Holdings Com New | 0.0 | $240k | 45k | 5.34 | |
Kronos Bio (KRON) | 0.0 | $98k | 78k | 1.25 | |
Allovir (ALVR) | 0.0 | $56k | 82k | 0.68 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $8.0k | 133k | 0.06 | |
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.9k | 100k | 0.02 |